DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Canada
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
GTII logo

Green Thumb Industries Inc. Stock Price

CNSX:GTII Community·CA$2.3b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 31 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

GTII Share Price Performance

CA$10.85
-0.22 (-1.99%)
​
CA$20.31
Fair Value
CA$10.85
-0.22 (-1.99%)
46.6% undervalued intrinsic discount
CA$20.31
Fair Value
Price CA$10.85
AnalystConsensusTarget CA$20.31
AnalystLowTarget CA$18.45
AnalystHighTarget CA$25.66
Thu, 11 Jun 26
Fair ValueCA$20.31
Share Pricen/a

GTII Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value CA$20.31 46.6% undervalued intrinsic discount

Minnesota Launch And New Cannabis Markets Will Expand Footprint

0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value CA$18.45 41.2% undervalued intrinsic discount

Regulatory Uncertainty And Oversupply Will Hamper Progress Yet Spark Resilience

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value CA$25.66 57.7% undervalued intrinsic discount

Federal Legalization And Wellness Trends Will Transform Cannabis Markets

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
GTII logo
Green Thumb Industries
46.6% undervalued intrinsic discount

Minnesota Launch And New Cannabis Markets Will Expand Footprint

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 11 Jun
Read Narrative
GTII logo
Green Thumb Industries
41.2% undervalued intrinsic discount

Regulatory Uncertainty And Oversupply Will Hamper Progress Yet Spark Resilience

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 9 Jul
Read Narrative
GTII logo
Green Thumb Industries
57.7% undervalued intrinsic discount

Federal Legalization And Wellness Trends Will Transform Cannabis Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 25 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
GTII logo

GTII: Partial Rescheduling Order Will Support Future Upside In Key Markets

Fair Value: CA$18.45 41.2% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
GTII logo

GTII: Partial Cannabis Rescheduling Will Support Future Rerating Despite Medical Efficacy Concerns

Fair Value: CA$25.66 57.7% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
GTII logo

GTII: Rescheduling Order And Buybacks Will Support Higher Future Share Price

Fair Value: CA$20.31 46.6% undervalued intrinsic discount
15 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Very undervalued with solid track record.

1 Risk
5 Rewards
View Full Analysis

Green Thumb Industries Inc. Key Details

US$1.2b

Revenue

US$642.5m

Cost of Revenue

US$566.9m

Gross Profit

US$440.1m

Other Expenses

US$126.8m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
0.58
46.87%
10.48%
15.2%
View Full Analysis

About GTII

Founded
2014
Employees
4900
CEO
Benjamin Kovler
WebsiteView website
www.gtigrows.com

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to third-party licensed retail customers; and sells finished products to third-party licensed retail cannabis stores. Green Thumb Industries Inc. was founded in 2014 and is headquartered in Chicago, Illinois.

Recent GTII News & Updates

Analysis Article • Aug 07

The Green Thumb Industries Inc. (CSE:GTII) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Last week, you might have seen that Green Thumb Industries Inc. ( CSE:GTII ) released its second-quarter result to the...

Recent updates

No updates

Green Thumb Industries Inc. Competitors

APTX logo

Apotex Health

Symbol: TSX:APTX
Market cap: CA$7.7b
CURA logo

Curaleaf Holdings

Symbol: TSX:CURA
Market cap: CA$3.6b
CRON logo

Cronos Group

Symbol: TSX:CRON
Market cap: CA$1.6b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide